Use of angiopoietin-2 as a biomarker in vascular anomalies beyond complex lymphatic anomalies
Svatava Merkle(Cincinnati Children's Hospital Medical Center), Elissa Engel(Cincinnati Children's Hospital Medical Center), Kiersten Ricci(Cincinnati Children's Hospital Medical Center), Timothy LeCras(Cincinnati Children's Hospital Medical Center), Adrienne M. Hammill(Cincinnati Children's Hospital Medical Center)
Cited by 0
Related Papers
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham–Stout disease
|Pediatric Blood & Cancer|2019|126
Vascular Anomalies
|Hematology/Oncology Clinics of North America|2019|122
How we approach the diagnosis and management of complex lymphatic anomalies
|Pediatric Blood & Cancer|2021|52
Advances in the Medical Management of Vascular Anomalies
|Seminars in Interventional Radiology|2017|47
Infantile Hemangiomas in the Head and Neck Region
|Otolaryngologic Clinics of North America|2017|42